고분자 생체 재료 시장(2024-2028년)

The polymeric biomaterials market is forecasted to grow by USD 8.10 bn during 2023-2028, accelerating at a CAGR of 10.01% during the forecast period. The report on the polymeric biomaterials market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for medical and dental implants, rising number of hip and knee replacement surgeries, and increasing prevalence of dental diseases.

Technavio's polymeric biomaterials market is segmented as below:

By Type

• Natural polymers
• Synthetic polymers
• Degradable polymers

By Application

• Orthopedics
• Cardiovascular
• Dental
• Plastic surgery
• Neurology and others

By Geographical Landscape

• North America
• Europe
• APAC
• South America
• Middle East and Africa

This study identifies the rising use of polymeric biomaterials in tissue engineering as one of the prime reasons driving the polymeric biomaterials market growth during the next few years. Also, increasing application of polymeric biomaterials in clinical applications and rising use of polymeric biomaterials in skin and soft tissue diseases will lead to sizable demand in the market.

The report on the polymeric biomaterials market covers the following areas:

• Polymeric biomaterials market sizing
• Polymeric biomaterials market forecast
• Polymeric biomaterials market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading polymeric biomaterials market vendors that include Anika Therapeutics Inc., Aspire Biotech Inc., BASF SE, Berkeley Advanced Biomaterials, Bezwada Biomedical LLC, Corbion nv, Covestro AG, Danimer Scientific Inc., International Polymer Engineering, Koninklijke DSM NV, Medtronic Plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., RAG Stiftung, Regenity, REVA Medical LLC, RevBio Inc., Stryker Corp., Victrex Plc, and Zimmer Biomet Holdings Inc.. Also, the polymeric biomaterials market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global polymeric biomaterials market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global polymeric biomaterials market 2018 - 2022 ($ billion)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.3 Application Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Natural polymers - Market size and forecast 2023-2028
• Exhibit 34: Chart on Natural polymers - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Natural polymers - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Natural polymers - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Natural polymers - Year-over-year growth 2023-2028 (%)
• 6.4 Synthetic polymers - Market size and forecast 2023-2028
• Exhibit 38: Chart on Synthetic polymers - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Synthetic polymers - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Synthetic polymers - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Synthetic polymers - Year-over-year growth 2023-2028 (%)
• 6.5 Degradable polymers - Market size and forecast 2023-2028
• Exhibit 42: Chart on Degradable polymers - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Degradable polymers - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Degradable polymers - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Degradable polymers - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Type
• Exhibit 46: Market opportunity by Type ($ billion)
• Exhibit 47: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 48: Chart on Application - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Application - Market share 2023-2028 (%)
• 7.2 Comparison by Application
• Exhibit 50: Chart on Comparison by Application
• Exhibit 51: Data Table on Comparison by Application
• 7.3 Orthopaedics - Market size and forecast 2023-2028
• Exhibit 52: Chart on Orthopaedics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Orthopaedics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Orthopaedics - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Orthopaedics - Year-over-year growth 2023-2028 (%)
• 7.4 Cardiovascular - Market size and forecast 2023-2028
• Exhibit 56: Chart on Cardiovascular - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Cardiovascular - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Cardiovascular - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Cardiovascular - Year-over-year growth 2023-2028 (%)
• 7.5 Dental - Market size and forecast 2023-2028
• Exhibit 60: Chart on Dental - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Dental - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Dental - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Dental - Year-over-year growth 2023-2028 (%)
• 7.6 Plastic surgery - Market size and forecast 2023-2028
• Exhibit 64: Chart on Plastic surgery - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on Plastic surgery - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on Plastic surgery - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Plastic surgery - Year-over-year growth 2023-2028 (%)
• 7.7 Neurology and others - Market size and forecast 2023-2028
• Exhibit 68: Chart on Neurology and others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Data Table on Neurology and others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 70: Chart on Neurology and others - Year-over-year growth 2023-2028 (%)
• Exhibit 71: Data Table on Neurology and others - Year-over-year growth 2023-2028 (%)
• 7.8 Market opportunity by Application
• Exhibit 72: Market opportunity by Application ($ billion)
• Exhibit 73: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 APAC - Market size and forecast 2023-2028
• Exhibit 87: Chart on APAC - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on APAC - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on APAC - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on APAC - Year-over-year growth 2023-2028 (%)
• 9.6 South America - Market size and forecast 2023-2028
• Exhibit 91: Chart on South America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on South America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on South America - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on South America - Year-over-year growth 2023-2028 (%)
• 9.7 Middle East and Africa - Market size and forecast 2023-2028
• Exhibit 95: Chart on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on Middle East and Africa - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on Middle East and Africa - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Middle East and Africa - Year-over-year growth 2023-2028 (%)
• 9.8 US - Market size and forecast 2023-2028
• Exhibit 99: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 Germany - Market size and forecast 2023-2028
• Exhibit 107: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 111: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 112: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 113: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 114: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Japan - Market size and forecast 2023-2028
• Exhibit 115: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 116: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 117: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 118: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.13 Market opportunity By Geographical Landscape
• Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 121: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 123: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 124: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 125: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 126: Matrix on vendor position and classification
• 12.3 Anika Therapeutics Inc.
• Exhibit 127: Anika Therapeutics Inc. - Overview
• Exhibit 128: Anika Therapeutics Inc. - Product / Service
• Exhibit 129: Anika Therapeutics Inc. - Key offerings
• 12.4 BASF SE
• Exhibit 130: BASF SE - Overview
• Exhibit 131: BASF SE - Business segments
• Exhibit 132: BASF SE - Key news
• Exhibit 133: BASF SE - Key offerings
• Exhibit 134: BASF SE - Segment focus
• 12.5 Berkeley Advanced Biomaterials
• Exhibit 135: Berkeley Advanced Biomaterials - Overview
• Exhibit 136: Berkeley Advanced Biomaterials - Product / Service
• Exhibit 137: Berkeley Advanced Biomaterials - Key offerings
• 12.6 Bezwada Biomedical LLC
• Exhibit 138: Bezwada Biomedical LLC - Overview
• Exhibit 139: Bezwada Biomedical LLC - Product / Service
• Exhibit 140: Bezwada Biomedical LLC - Key offerings
• 12.7 Corbion nv
• Exhibit 141: Corbion nv - Overview
• Exhibit 142: Corbion nv - Business segments
• Exhibit 143: Corbion nv - Key news
• Exhibit 144: Corbion nv - Key offerings
• Exhibit 145: Corbion nv - Segment focus
• 12.8 International Polymer Engineering
• Exhibit 146: International Polymer Engineering - Overview
• Exhibit 147: International Polymer Engineering - Product / Service
• Exhibit 148: International Polymer Engineering - Key offerings
• 12.9 Koninklijke DSM NV
• Exhibit 149: Koninklijke DSM NV - Overview
• Exhibit 150: Koninklijke DSM NV - Business segments
• Exhibit 151: Koninklijke DSM NV - Key news
• Exhibit 152: Koninklijke DSM NV - Key offerings
• Exhibit 153: Koninklijke DSM NV - Segment focus
• 12.10 Medtronic Plc
• Exhibit 154: Medtronic Plc - Overview
• Exhibit 155: Medtronic Plc - Business segments
• Exhibit 156: Medtronic Plc - Key news
• Exhibit 157: Medtronic Plc - Key offerings
• Exhibit 158: Medtronic Plc - Segment focus
• 12.11 Meril Life Sciences Pvt. Ltd.
• Exhibit 159: Meril Life Sciences Pvt. Ltd. - Overview
• Exhibit 160: Meril Life Sciences Pvt. Ltd. - Product / Service
• Exhibit 161: Meril Life Sciences Pvt. Ltd. - Key offerings
• 12.12 MicroPort Scientific Corp.
• Exhibit 162: MicroPort Scientific Corp. - Overview
• Exhibit 163: MicroPort Scientific Corp. - Business segments
• Exhibit 164: MicroPort Scientific Corp. - Key offerings
• Exhibit 165: MicroPort Scientific Corp. - Segment focus
• 12.13 RAG Stiftung
• Exhibit 166: RAG Stiftung - Overview
• Exhibit 167: RAG Stiftung - Product / Service
• Exhibit 168: RAG Stiftung - Key offerings
• 12.14 REVA Medical LLC
• Exhibit 169: REVA Medical LLC - Overview
• Exhibit 170: REVA Medical LLC - Product / Service
• Exhibit 171: REVA Medical LLC - Key offerings
• 12.15 Stryker Corp.
• Exhibit 172: Stryker Corp. - Overview
• Exhibit 173: Stryker Corp. - Business segments
• Exhibit 174: Stryker Corp. - Key news
• Exhibit 175: Stryker Corp. - Key offerings
• Exhibit 176: Stryker Corp. - Segment focus
• 12.16 Victrex Plc
• Exhibit 177: Victrex Plc - Overview
• Exhibit 178: Victrex Plc - Business segments
• Exhibit 179: Victrex Plc - Key offerings
• Exhibit 180: Victrex Plc - Segment focus
• 12.17 Zimmer Biomet Holdings Inc.
• Exhibit 181: Zimmer Biomet Holdings Inc. - Overview
• Exhibit 182: Zimmer Biomet Holdings Inc. - Business segments
• Exhibit 183: Zimmer Biomet Holdings Inc. - Key news
• Exhibit 184: Zimmer Biomet Holdings Inc. - Key offerings
• Exhibit 185: Zimmer Biomet Holdings Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 186: Inclusions checklist
• Exhibit 187: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 188: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 189: Research methodology
• Exhibit 190: Validation techniques employed for market sizing
• Exhibit 191: Information sources
• 13.5 List of abbreviations
• Exhibit 192: List of abbreviations